SU | ||
---|---|---|
OUTLOOK RATING 1..100 | 62 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 33 Fair valued | |
PROFIT vs RISK RATING 1..100 | 30 | |
SMR RATING 1..100 | 57 | |
PRICE GROWTH RATING 1..100 | 50 | |
P/E GROWTH RATING 1..100 | 27 | |
SEASONALITY SCORE 1..100 | 32 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
PTEU | SU | |
---|---|---|
RSI ODDS (%) | 1 day ago90% | N/A |
Stochastic ODDS (%) | 1 day ago77% | 1 day ago62% |
Momentum ODDS (%) | 1 day ago62% | 1 day ago62% |
MACD ODDS (%) | 1 day ago77% | 1 day ago64% |
TrendWeek ODDS (%) | 1 day ago76% | 1 day ago60% |
TrendMonth ODDS (%) | 1 day ago64% | 1 day ago69% |
Advances ODDS (%) | 1 day ago80% | 11 days ago70% |
Declines ODDS (%) | 8 days ago71% | 1 day ago64% |
BollingerBands ODDS (%) | 1 day ago86% | 1 day ago63% |
Aroon ODDS (%) | 1 day ago75% | N/A |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
GSIE | 40.06 | 0.33 | +0.83% |
Goldman Sachs ActiveBeta® Intl Eq ETF | |||
TYLD | 25.34 | 0.01 | +0.06% |
Cambria Tactical Yield ETF | |||
CPST | 26.37 | -0.01 | -0.03% |
Calamos S&P 500 Str Alt Prt ETF-Sep | |||
SPFF | 9.14 | -0.01 | -0.12% |
Global X SuperIncome™ Preferred ETF | |||
BME | 35.17 | -0.20 | -0.57% |
Blackrock Health Sciences Trust |
A.I.dvisor tells us that PTEU and ALV have been poorly correlated (+12% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PTEU and ALV's prices will move in lockstep.
Ticker / NAME | Correlation To PTEU | 1D Price Change % | ||
---|---|---|---|---|
PTEU | 100% | +1.11% | ||
ALV - PTEU | 12% Poorly correlated | -0.64% | ||
OR - PTEU | 6% Poorly correlated | +2.29% | ||
FTI - PTEU | 2% Poorly correlated | -1.27% | ||
SU - PTEU | -5% Poorly correlated | -0.51% | ||
AI - PTEU | -11% Poorly correlated | -2.54% |